University of Edinburgh
Edinburgh, Midlothian, EH16 4SB, United Kingdom
NCT Number: NCT00737958
The purpose of this study is to determine whether exposure to diesel exhaust (air pollution) has a functional impact on patients with stable angina pectoris.
Looking for future studies?
Notify MeAll sexes
Observational
Edinburgh, Midlothian, EH16 4SB, United Kingdom
Air pollution is a major cause of cardiovascular morbidity and mortality. The mechanism and components of air pollution responsible for these cardiovascular effects are unknown but small combustion-derived particles are suspected to be the major cause. Using a unique exposure system in Umeå Sweden, we have demonstrated that healthy volunteers who inhale dilute diesel exhaust develop an impairment of two important, highly relevant and complementary aspects of vascular function: the regulation of vascular tone and endogenous fibrinolysis. We have recently extended these findings and have shown that brief exposure to dilute diesel exhaust promotes myocardial ischemia and inhibits endogenous fibrinolytic capacity in patients with stable asymptomatic coronary heart disease. We now wish to extend these findings to patients with chronic stable angina pectoris. In particular, we wish to determine the functional impact of diesel exhaust inhalation as well as describe the time course and minimum exposure that can induce these detrimental effects.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Immediately after exposure
Time frame: 24hrs after exposure
Time frame: Immediately after exposure
Time frame: Before, after and at 24 hours after exposure
University of Edinburgh
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00500617
Angina Pectoris, Arterial Occlusive Diseases
Anchorage, Alaska, United States
View Trial DetailsNCT01117506
Angina Pectoris, Arterial Occlusive Diseases
Long Beach, California, United States
View Trial DetailsNCT01557855
Angina Pectoris, Arterial Occlusive Diseases
Gilbert, Arizona, United States
View Trial DetailsNCT01594411
Angina Pectoris, Arterial Occlusive Diseases
Suwanee, Georgia, United States
View Trial Details